Related Experiment Video
Updated: Apr 22, 2026

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
Published on: August 5, 2022
5-azacytidine inhibits nonsense-mediated decay in a MYC-dependent fashion
Madhuri Bhuvanagiri1, Joe Lewis2, Kerstin Putzker2
1Molecular Medicine Partnership Unit, European Molecular Biology Laboratory, University of Heidelberg, Heidelberg, Germany Department of Pediatric Oncology, Hematology and Immunology, University of Heidelberg, Heidelberg, Germany European Molecular Biology Laboratory, Heidelberg, Germany.
Abstract:
Nonsense-mediated RNA decay (NMD) is an RNA-based quality control mechanism that eliminates transcripts bearing premature translation termination codons (PTC). Approximately, one-third of all inherited disorders and some forms of cancer are caused by nonsense or frame shift mutations that introduce PTCs, and NMD can modulate the clinical phenotype of these diseases. 5-azacytidine is an analogue of the naturally occurring pyrimidine nucleoside cytidine, which is approved for the treatment of myelodysplastic syndrome and myeloid leukemia. Here, we reveal that 5-azacytidine inhibits NMD in a dose-dependent fashion specifically upregulating the expression of both PTC-containing mutant and cellular NMD targets. Moreover, this activity of 5-azacytidine depends on the induction of MYC expression, thus providing a link between the effect of this drug and one of the key cellular pathways that are known to affect NMD activity. Furthermore, the effective concentration of 5-azacytidine in cells corresponds to drug levels used in patients, qualifying 5-azacytidine as a candidate drug that could potentially be repurposed for the treatment of Mendelian and acquired genetic diseases that are caused by PTC mutations.
Insights
5-azacytidine inhibits nonsense-mediated RNA decay (NMD), a process that removes faulty transcripts. This drug upregulates gene expression and may offer new treatments for genetic diseases caused by premature stop codons.
Area of Science:
- Molecular Biology
- Genetics
- Pharmacology
Background:
- Nonsense-mediated RNA decay (NMD) is a crucial cellular surveillance pathway that degrades messenger RNAs containing premature translation termination codons (PTCs).
- PTCs arise from mutations in approximately one-third of inherited genetic disorders and some cancers, influencing disease severity.
- 5-azacytidine is an FDA-approved drug for myelodysplastic syndrome and myeloid leukemia, acting as a cytidine analogue.
Purpose of the Study:
- To investigate the effect of 5-azacytidine on NMD activity.
- To determine the molecular mechanisms underlying 5-azacytidine's impact on NMD.
- To explore the potential therapeutic applications of 5-azacytidine for PTC-related genetic diseases.
Main Methods:
- Dose-dependent treatment of cells with 5-azacytidine.
- Quantitative analysis of NMD target gene expression.
- Investigation of MYC gene expression levels and its role in NMD modulation.
Main Results:
- 5-azacytidine demonstrated a dose-dependent inhibition of NMD.
- The drug specifically upregulated the expression of both mutant PTC-containing transcripts and endogenous NMD targets.
- This NMD inhibition was dependent on the induction of MYC expression, linking 5-azacytidine's action to MYC signaling pathways.
- Effective cellular concentrations of 5-azacytidine align with therapeutic levels used in patients.
Conclusions:
- 5-azacytidine effectively inhibits NMD through MYC induction.
- The drug's ability to upregulate PTC-containing transcripts suggests potential for treating genetic disorders caused by PTC mutations.
- 5-azacytidine represents a promising candidate for drug repurposing in Mendelian and acquired genetic diseases associated with PTCs.
Related Concept Videos
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Nonsense-mediated mRNA Decay
Nuclear Export of mRNA
Abnormal Proliferation
Inhibitors of Bacterial Protein Synthesis
Anaphase Promoting Complex

